ir.theravance.com
Investor Overview : InnovivaThe Investor Relations website contains information about Innoviva business for stockholders, potential investors, and financial analysts.
http://ir.theravance.com/
The Investor Relations website contains information about Innoviva business for stockholders, potential investors, and financial analysts.
http://ir.theravance.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Saturday
LOAD TIME
0.9 seconds
16x16
32x32
64x64
128x128
PAGES IN
THIS WEBSITE
20
SSL
EXTERNAL LINKS
0
SITE IP
206.200.251.19
LOAD TIME
0.9 sec
SCORE
6.2
Investor Overview : Innoviva | ir.theravance.com Reviews
https://ir.theravance.com
The Investor Relations website contains information about Innoviva business for stockholders, potential investors, and financial analysts.
ir.theravance.com
Stock Information : Innoviva
http://ir.theravance.com/stockquote.cfm
017 ( 1.516%). 4:00 PM ET on Aug 26, 2016. The stock information provided is for informational purposes only and is not intended for trading purposes. The stock information is provided by eSignal, stock charts are provided by EDGAR Online, both third party services, and Innoviva does not maintain or provide information directly to this service. Stock information is delayed approximately 20 minutes. Sign up for email alerts. 08/26/16 4:00 PM ET. Data provided by Nasdaq. Minimum 15 minutes delayed.
GSK Receives Approval for BREO(R) ELLIPTA(R) for the Treatment of Adults With Asthma (NASDAQ:INVA)
http://ir.theravance.com/releasedetail.cfm?ReleaseID=926497
Aug 6, 2015. File is in Briefcase. GSK Receives Approval for BREO(R) ELLIPTA(R) for the Treatment of Adults With Asthma. LONDON, UNITED KINGDOM. SOUTH SAN FRANCISCO, CA. GSK (LSE: GSK) and. NASDAQ: THRX) announce the approval in. Of BREO ELLIPTA (fluticasone furoate/vilanterol dry powder for oral inhalation) for the once-daily maintenance treatment of asthma in patients aged 18 years and older with reversible obstructive airways disease. Country Medical Officer,. Michael W. Aguiar. For complete safety in...
Board of Directors : Innoviva
http://ir.theravance.com/directors.cfm
William H. Waltrip. Michael W. Aguiar. President and Chief Executive Officer. Catherine J. Friedman. James L. Tyree. William H. Waltrip. William H. Waltrip. Back to Board of Directors. Michael W. Aguiar. President and Chief Executive Officer. Michael W. Aguiar. Back to Board of Directors. Catherine J. Friedman. Catherine J. Friedman. Member of the Audit Committee. Member of the Compensation Committee. Back to Board of Directors. Chair of the Audit Committee. Back to Board of Directors. James L. Tyree.
Email Alerts Subscription : Innoviva
http://ir.theravance.com/profile.cfm
Step 1 of 3: Select Options. You may automatically receive Innoviva financial information by email. Please enter your preferences for email notifications below and click Continue to enter your contact information on the next page. If you have already signed up and would like to review your subscription, click here. Quarterly and Annual Reports. All Events and Presentations. In advance of any event. Unsubscribe from Investor Relations email alerts. 08/26/16 4:00 PM ET. Data provided by Nasdaq.
Theravance Reports Second Quarter 2015 Financial Results (NASDAQ:INVA)
http://ir.theravance.com/releasedetail.cfm?ReleaseID=924581
Jul 29, 2015. File is in Briefcase. Theravance Reports Second Quarter 2015 Financial Results. Theravance Declares a $0.25 per Share Dividend for Q3 2015; Theravance to Host Conference Call and Webcast Today at 5:00 pm EDT. SOUTH SAN FRANCISCO, CA. NASDAQ: THRX) today reported financial results for the second quarter ended. June 30, 2015. Royalties from sales of RELVAR. GSK) during the second quarter of 2015 were. In the first quarter, while adjusted EBITDA for the second quarter of 2015 was. June 30, 2015.
TOTAL PAGES IN THIS WEBSITE
20
Intercontinental Exchange – Investors & Media
Skip to main content. Press Kit and Publications. News Features and Awards. Annual and Quarterly Reports. 2017 Letter to Shareholders. Governance and Charter Documents. Historical ICE Inc Filings. Press Kit and Publications. News Features and Awards. Annual and Quarterly Reports. 2017 Letter to Shareholders. Governance and Charter Documents. Historical ICE Inc Filings. ICE Publishes 2017 Annual Report. Announcing our CSR Report. World-leading environmental markets and largest venue for green ETFs. Interc...
Digital Cameras, Digital Camera Reviews - The Imaging Resource!
Canon 5D Mark III. Lens Reviews on SLR Gear. New on the site. Reviews by SLR Gear Readers. A bumpy road for early adopters, but a winner in the end. Ricoh's all-weather shooter reinvents the DSLR for the selfie generation. Pentax K-3 II Field Test Part I. Could this be the best argument yet for shooting raw? Canon T6S Field Test. A beefed-up entry-level DSLR bridges gap toward enthusiasts. Nikon D7200 Field Test Part I. Beating the heatwave with one mighty cool camera! Olympus E-M5 II Review. Nikon 18-14...
Investor Relations | The Joint ...the chiropractic place
We've attempted to automatically locate the clinic nearest you. If you don't believe this to be your closest clinic, please click the "Change" link above or use the "Find Your Clinic" link below. An Attractive Business Model. Board Committee Charters and Policies. Our mission is to improve quality of life through routine and affordable chiropractic care. Today's Hours: 10:00PM - 7:00PM. Board Committee Charters and Policies. Joint Corp 2015 Second Quarter Results. 160;at 11:00 am ET. 160; 0.11.
The Medicines Company - Investors - Investor Relations Home
Acute Intensive Care Medicine. Angiomax (bivalirudin) for Injection. Argatroban Injection, 50 mg per 50 mL. Cleviprex (clevidipine) Injectable Emulsion. Recothrom Thrombin, topical (Recombinant). The Medicines Company Conference Call to Discuss Clinical Trial Results of ABP-700 and MDCO-216. 160;at 8:30 am ET. The Medicines Company at Jefferies 2015 Global Healthcare Conference. 160;at 10:00 am ET. The Medicines Company at Bank of America Merrill Lynch 2015 Health Care Conference. 160;at 10:00 am PT.
Investors & Media | TXMD
TX001HR (Oral Estradiol Progesterone). Logos and Media Resources. Logos and Media Resources. TherapeuticsMD, Inc. is an innovative healthcare company focused on developing and commercializing products exclusively for women. With its SYMBODA technology, TherapeuticsMD is developing advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. The company’s clinical development pipeline includes two pha...
Investor Overview : Innoviva
Innoviva (NASDAQ: INVA) is focused on bringing compelling new medicines to patients in areas of unmet need by leveraging its significant expertise in the development, commercialization and financial management of bio-pharmaceuticals. Innoviva’s portfolio is anchored by the respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR/BREO ELLIPTA and ANORO ELLIPTA, which were jointly developed by Innoviva and GSK. Feb 14, 2018. Feb 8, 2018. Feb 2, 2018. Jan 26, 2018. 03/29/18 4:00 PM ET.
Thermo Fisher Scientific - Investor Overview
GAAP/Non-GAAP Reconciliation and Financial Package. Stock Quote and Chart. Board Committees and Charters. Code of Business Conduct and Ethics. GAAP/Non-GAAP Reconciliation and Financial Package. Stock Quote and Chart. Board Committees and Charters. Code of Business Conduct and Ethics. Feb 27, 2018. Thermo Fisher Scientific Innovations Offer Greater Connectivity and Ease of Use. Jan 31, 2018. Jan 31, 2018. Thermo Fisher Scientific Increases Quarterly Dividend. More than $20 billion in annual revenue and.
Investor Relations | Thermon
Skip to main navigation. Industrial Electric Heat Tracing. CEMS / Analyzer Umbilicals. Commercial Electric Heat Tracing. Complex Piping Design Guide. Parallel Constant Watt Cables. Series Constant Watt Cables. Mineral Insulated Heating Cables. Tank Insulation /Tank and Hopper Heating. HT Hopper Heating Module. Mechanical Control and Monitoring. Electronic Control and Monitoring. Heat Transfer Compounds (Cement). TubeTrace Pre-Insulated and Heated Instrument Tubing Bundles. Tank and Vessel Heating Units.
TheSeniorDatingAgency.com Ireland :: Login
Login to your account. Member ID or Email. Remember my member ID. Do not check this if you are on a public machine. Login to TheSeniorDatingAgency.com Ireland. Email our support team with your member ID if you are having trouble logging in. Not yet a member? Join now for free.
Corporate Profile
Access Your Online Banking Account. Enroll in Online Banking. Third Federal Savings and Loan. Buying an Existing Home. Build a New Home. Reduce Your Mortgage Rate. Reduce Your Mortgage Payment. Lower Your Home Equity Payment. Pay Off Your Mortgage Faster. Pay for a One-Time Expense or Event. Pay for a Recurring Expense or Event. A Great Rate. Easy as that. Third Federal Certificates of Deposit. Rates as Low as 2.49%. Mortgage and Savings Calculators. The Third Federal Difference. Enroll In Online Banking.
Investor Relations | Investor Relations | Thomson Reuters
Our Policy Towards The Use Of Cookies. All Thomson Reuters websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser. Annual and Quarterly Reports. Annual and Quarterly Reports. Data provided by Nasdaq. Minimum 15 minutes delayed. Thomson Reuters Reports Second-Quarter 2015 Results. Wednesday, July 29, 2015. 160;at 8:30 am ET. Thomson Reuters Reports Second-Quarter 2015 Results. Our fi...
